Marker Therapeutics, Inc. (MRKR) Institutional Ownership

Ownership Summary

A total of 9 institutions have reported a stake in Marker Therapeutics, Inc. (NASDAQ:MRKR) as of December 2025, according to recent 13F filings with the SEC.

• The percentage of Marker Therapeutics owned by institutions changed from 20.6% in September 2025 to 3.6% in December 2025, marking a slight down trend.
• On a quarter-over-quarter basis, institutional holdings shifted by 79.60%, with a year-over-year a decrease of 73.53% in the count of filers.
• A review of institutional activity for Marker Therapeutics shows 5 of 9 filers increasing their positions, while 0 reduced their stake, and 4 remained unchanged.
• The total number of shares held by institutions in Marker Therapeutics increased to 594.19K as of December 2025, a net change of up by 263.34K shares quarter on quarter, and down 3.86Mn shares year over year.
• VANGUARD GROUP INC continues to be the largest institutional holder of Marker Therapeutics as of December 31, 2025, with a position of 346.07K shares, representing 2.08% of the company's outstanding stock.
• Among the most significant buyers of Marker Therapeutics during December 2025 were UBS Group AG (168.23K), VANGUARD GROUP INC (46.29K), Boyer Financial Services, Inc. (36.82K), FIFTH THIRD BANCORP (10.00K), INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC (2.00K).
• The top 9 institutional holders of Marker Therapeutics for the quarter ending December 2025 included VANGUARD GROUP INC (346.07K), UBS Group AG (174.03K), Boyer Financial Services, Inc. (36.82K), MATRIX ASSET ADVISORS INC/NY (15.00K), Ashton Thomas Private Wealth, LLC (10.00K), FIFTH THIRD BANCORP (10.00K), INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC (2.00K), SBI Securities Co., Ltd. (203), Hilltop National Bank (73).